Search research articles
Contact Us
Filters
Showing results (11-20 of 110) with videos related to
Page
of 11
Sort By:
The Medical Clinics of North America
|
May 7, 2013
FDG-PET in early AD diagnosis
Jessica Chew, Daniel H S Silverman
Seminars in Nuclear Medicine
|
October 3, 2012
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition
Nare Torosyan, Daniel H S Silverman
The American Journal of Psychiatry
|
August 31, 2002
Prompt identification of Alzheimer's disease with brain PET imaging of a woman with multiple previous diagnoses of other neuropsychiatric conditions
Daniel H S Silverman, Gary W Small
Molecular Imaging and Biology
|
October 11, 2003
Assessing brain biochemistry in the early evaluation of dementia: can we afford the improved diagnostic accuracy obtained by incorporating cerebral metabolic data acquired with positron emission tomography into the clinical work-up?
Daniel H S Silverman, Michael E Phelps
Expert Review of Molecular Diagnostics
|
January 9, 2004
Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease
Carol Y Chang, Daniel H S Silverman
American Journal of Alzheimer'S Disease and Other Dementias
|
April 26, 2006
Recognition and treatment of Alzheimer's disease: a case-based review
Dana M Marseille, Daniel H S Silverman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 17, 2022
Reply: Posterior Cingulate Involvement Does Not Argue Against LATE-And Who Said It Does?
Angela C Rieger, Daniel H S Silverman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 2022
Is It Too Soon to Know When It's LATE?
Angela C Rieger, Daniel H S Silverman
Journal of Alzheimer'S Disease : JAD
|
August 18, 2020
Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders
Cyrus A Raji, Nare Torosyan, Daniel H S Silverman
Seminars in Nuclear Medicine
|
October 9, 2007
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors
John P Seibyl, Wei Chen, Daniel H S Silverman
Page
of 11
Search research articles
Search
Showing results (11-20 of 110) with videos related to
Sort By:
Page
of 11
The Medical Clinics of North America
|
May 7, 2013
FDG-PET in early AD diagnosis
Jessica Chew, Daniel H S Silverman
Seminars in Nuclear Medicine
|
October 3, 2012
Neuronuclear imaging in the evaluation of dementia and mild decline in cognition
Nare Torosyan, Daniel H S Silverman
The American Journal of Psychiatry
|
August 31, 2002
Prompt identification of Alzheimer's disease with brain PET imaging of a woman with multiple previous diagnoses of other neuropsychiatric conditions
Daniel H S Silverman, Gary W Small
Molecular Imaging and Biology
|
October 11, 2003
Assessing brain biochemistry in the early evaluation of dementia: can we afford the improved diagnostic accuracy obtained by incorporating cerebral metabolic data acquired with positron emission tomography into the clinical work-up?
Daniel H S Silverman, Michael E Phelps
Expert Review of Molecular Diagnostics
|
January 9, 2004
Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease
Carol Y Chang, Daniel H S Silverman
American Journal of Alzheimer'S Disease and Other Dementias
|
April 26, 2006
Recognition and treatment of Alzheimer's disease: a case-based review
Dana M Marseille, Daniel H S Silverman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 17, 2022
Reply: Posterior Cingulate Involvement Does Not Argue Against LATE-And Who Said It Does?
Angela C Rieger, Daniel H S Silverman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 2022
Is It Too Soon to Know When It's LATE?
Angela C Rieger, Daniel H S Silverman
Journal of Alzheimer'S Disease : JAD
|
August 18, 2020
Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders
Cyrus A Raji, Nare Torosyan, Daniel H S Silverman
Seminars in Nuclear Medicine
|
October 9, 2007
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors
John P Seibyl, Wei Chen, Daniel H S Silverman
Page
of 11